Large Volume Parenteral (LVP) Industry Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Large Volume Parenteral (LVP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Parenteral (LVP).
The Large Volume Parenteral (LVP) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Large Volume Parenteral (LVP) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Volume Parenteral (LVP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Large Volume Parenteral (LVP) type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Large Volume Parenteral (LVP) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Large Volume Parenteral (LVP) segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Large Volume Parenteral (LVP) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Large Volume Parenteral (LVP) market.
Large Volume Parenteral (LVP) segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Large Volume Parenteral (LVP) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Volume Parenteral (LVP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Large Volume Parenteral (LVP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Large Volume Parenteral (LVP) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Volume Parenteral (LVP).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Large Volume Parenteral (LVP) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Large Volume Parenteral (LVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The Large Volume Parenteral (LVP) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Large Volume Parenteral (LVP) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Volume Parenteral (LVP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Baxter Healthcare
- Kelun Pharma
- B. Braun
- Fresenius
- Teva Pharmaceutical Industries
- Pfizer (Hospira)
- Ostuka Pharmaceutical
- CR Double-Crane
- Pisa
- Huaren
- Patheon
- Beximco Pharma
- Albert David
- PSI Ltd
- Ozon Pharmaceuticals
- BAG Healthcare
- BML Parenteral Drugs
Global markets are presented by Large Volume Parenteral (LVP) type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Large Volume Parenteral (LVP) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Large Volume Parenteral (LVP) segment by Type
- Soft Bag LVP
- Plastic Bottle LVP
- Glass Bottle LVP
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Large Volume Parenteral (LVP) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Large Volume Parenteral (LVP) market.
Large Volume Parenteral (LVP) segment by Application
- Basic Infusion
- Therapeutic Infusion
- Nutritious Infusion
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Large Volume Parenteral (LVP) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Volume Parenteral (LVP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Large Volume Parenteral (LVP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Large Volume Parenteral (LVP) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Volume Parenteral (LVP).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Large Volume Parenteral (LVP) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Large Volume Parenteral (LVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Large Volume Parenteral (LVP) Market Size (2018-2029) & (US$ Million)
2.2.2 Global Large Volume Parenteral (LVP) Sales (2018-2029)
2.2.3 Global Large Volume Parenteral (LVP) Market Average Price (2018-2029)
2.3 Large Volume Parenteral (LVP) by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
2.4 Large Volume Parenteral (LVP) by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Basic Infusion
2.4.3 Therapeutic Infusion
2.4.4 Nutritious Infusion
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Large Volume Parenteral (LVP) Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Large Volume Parenteral (LVP) Sales (M Units) of Manufacturers (2018-2023)
3.3 Global Large Volume Parenteral (LVP) Revenue of Manufacturers (2018-2023)
3.4 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2018-2023)
3.5 Global Large Volume Parenteral (LVP) Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
3.8 Global Manufacturers of Large Volume Parenteral (LVP), Date of Enter into This Industry
3.9 Global Large Volume Parenteral (LVP) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Baxter Healthcare
4.1.1 Baxter Healthcare Company Information
4.1.2 Baxter Healthcare Business Overview
4.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
4.1.5 Baxter Healthcare Recent Developments
4.2 Kelun Pharma
4.2.1 Kelun Pharma Company Information
4.2.2 Kelun Pharma Business Overview
4.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
4.2.5 Kelun Pharma Recent Developments
4.3 B. Braun
4.3.1 B. Braun Company Information
4.3.2 B. Braun Business Overview
4.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
4.3.5 B. Braun Recent Developments
4.4 Fresenius
4.4.1 Fresenius Company Information
4.4.2 Fresenius Business Overview
4.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
4.4.5 Fresenius Recent Developments
4.5 Teva Pharmaceutical Industries
4.5.1 Teva Pharmaceutical Industries Company Information
4.5.2 Teva Pharmaceutical Industries Business Overview
4.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments
4.6 Pfizer (Hospira)
4.6.1 Pfizer (Hospira) Company Information
4.6.2 Pfizer (Hospira) Business Overview
4.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
4.6.5 Pfizer (Hospira) Recent Developments
4.7 Ostuka Pharmaceutical
4.7.1 Ostuka Pharmaceutical Company Information
4.7.2 Ostuka Pharmaceutical Business Overview
4.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
4.7.5 Ostuka Pharmaceutical Recent Developments
6.8 CR Double-Crane
4.8.1 CR Double-Crane Company Information
4.8.2 CR Double-Crane Business Overview
4.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
4.8.5 CR Double-Crane Recent Developments
4.9 Pisa
4.9.1 Pisa Company Information
4.9.2 Pisa Business Overview
4.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
4.9.5 Pisa Recent Developments
4.10 Huaren
4.10.1 Huaren Company Information
4.10.2 Huaren Business Overview
4.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
4.10.5 Huaren Recent Developments
6.11 Patheon
6.11.1 Patheon Company Information
6.11.2 Patheon Large Volume Parenteral (LVP) Business Overview
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Patheon Recent Developments
6.12 Beximco Pharma
6.12.1 Beximco Pharma Company Information
6.12.2 Beximco Pharma Large Volume Parenteral (LVP) Business Overview
6.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Beximco Pharma Recent Developments
6.13 Albert David
6.13.1 Albert David Company Information
6.13.2 Albert David Large Volume Parenteral (LVP) Business Overview
6.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Albert David Recent Developments
6.14 PSI Ltd
6.14.1 PSI Ltd Company Information
6.14.2 PSI Ltd Large Volume Parenteral (LVP) Business Overview
6.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.14.5 PSI Ltd Recent Developments
6.15 Ozon Pharmaceuticals
6.15.1 Ozon Pharmaceuticals Company Information
6.15.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Business Overview
6.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.15.5 Ozon Pharmaceuticals Recent Developments
6.16 BAG Healthcare
6.16.1 BAG Healthcare Company Information
6.16.2 BAG Healthcare Large Volume Parenteral (LVP) Business Overview
6.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.16.5 BAG Healthcare Recent Developments
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Company Information
6.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments
5 GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET SCENARIO BY REGION
5.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Large Volume Parenteral (LVP) Sales by Region: 2018-2029
5.2.1 Global Large Volume Parenteral (LVP) Sales by Region: 2018-2023
5.2.2 Global Large Volume Parenteral (LVP) Sales by Region: 2024-2029
5.3 Global Large Volume Parenteral (LVP) Revenue by Region: 2018-2029
5.3.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2018-2023
5.3.2 Global Large Volume Parenteral (LVP) Revenue by Region: 2024-2029
5.4 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.4.1 North America Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.4.3 North America Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.5.1 Europe Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.5.3 Europe Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.6.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.6.3 Asia Pacific Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.7.1 Latin America Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.7.3 Latin America Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.8.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.8.3 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Large Volume Parenteral (LVP) Sales by Type (2018-2029)
6.1.1 Global Large Volume Parenteral (LVP) Sales by Type (2018-2029) & (M Units)
6.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2018-2029)
6.2 Global Large Volume Parenteral (LVP) Revenue by Type (2018-2029)
6.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2018-2029)
6.3 Global Large Volume Parenteral (LVP) Price by Type (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Large Volume Parenteral (LVP) Sales by Application (2018-2029)
7.1.1 Global Large Volume Parenteral (LVP) Sales by Application (2018-2029) & (M Units)
7.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2018-2029)
7.2 Global Large Volume Parenteral (LVP) Revenue by Application (2018-2029)
6.2.1 Global Large Volume Parenteral (LVP) Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2018-2029)
7.3 Global Large Volume Parenteral (LVP) Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Large Volume Parenteral (LVP) Value Chain Analysis
8.1.1 Large Volume Parenteral (LVP) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Large Volume Parenteral (LVP) Production Mode & Process
8.2 Large Volume Parenteral (LVP) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Large Volume Parenteral (LVP) Distributors
8.2.3 Large Volume Parenteral (LVP) Customers
9 GLOBAL LARGE VOLUME PARENTERAL (LVP) ANALYZING MARKET DYNAMICS
9.1 Large Volume Parenteral (LVP) Industry Trends
9.2 Large Volume Parenteral (LVP) Industry Drivers
9.3 Large Volume Parenteral (LVP) Industry Opportunities and Challenges
9.4 Large Volume Parenteral (LVP) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Large Volume Parenteral (LVP) Market Size (2018-2029) & (US$ Million)
2.2.2 Global Large Volume Parenteral (LVP) Sales (2018-2029)
2.2.3 Global Large Volume Parenteral (LVP) Market Average Price (2018-2029)
2.3 Large Volume Parenteral (LVP) by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
2.4 Large Volume Parenteral (LVP) by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Basic Infusion
2.4.3 Therapeutic Infusion
2.4.4 Nutritious Infusion
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Large Volume Parenteral (LVP) Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Large Volume Parenteral (LVP) Sales (M Units) of Manufacturers (2018-2023)
3.3 Global Large Volume Parenteral (LVP) Revenue of Manufacturers (2018-2023)
3.4 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2018-2023)
3.5 Global Large Volume Parenteral (LVP) Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
3.8 Global Manufacturers of Large Volume Parenteral (LVP), Date of Enter into This Industry
3.9 Global Large Volume Parenteral (LVP) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Baxter Healthcare
4.1.1 Baxter Healthcare Company Information
4.1.2 Baxter Healthcare Business Overview
4.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
4.1.5 Baxter Healthcare Recent Developments
4.2 Kelun Pharma
4.2.1 Kelun Pharma Company Information
4.2.2 Kelun Pharma Business Overview
4.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
4.2.5 Kelun Pharma Recent Developments
4.3 B. Braun
4.3.1 B. Braun Company Information
4.3.2 B. Braun Business Overview
4.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
4.3.5 B. Braun Recent Developments
4.4 Fresenius
4.4.1 Fresenius Company Information
4.4.2 Fresenius Business Overview
4.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
4.4.5 Fresenius Recent Developments
4.5 Teva Pharmaceutical Industries
4.5.1 Teva Pharmaceutical Industries Company Information
4.5.2 Teva Pharmaceutical Industries Business Overview
4.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments
4.6 Pfizer (Hospira)
4.6.1 Pfizer (Hospira) Company Information
4.6.2 Pfizer (Hospira) Business Overview
4.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
4.6.5 Pfizer (Hospira) Recent Developments
4.7 Ostuka Pharmaceutical
4.7.1 Ostuka Pharmaceutical Company Information
4.7.2 Ostuka Pharmaceutical Business Overview
4.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
4.7.5 Ostuka Pharmaceutical Recent Developments
6.8 CR Double-Crane
4.8.1 CR Double-Crane Company Information
4.8.2 CR Double-Crane Business Overview
4.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
4.8.5 CR Double-Crane Recent Developments
4.9 Pisa
4.9.1 Pisa Company Information
4.9.2 Pisa Business Overview
4.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
4.9.5 Pisa Recent Developments
4.10 Huaren
4.10.1 Huaren Company Information
4.10.2 Huaren Business Overview
4.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
4.10.5 Huaren Recent Developments
6.11 Patheon
6.11.1 Patheon Company Information
6.11.2 Patheon Large Volume Parenteral (LVP) Business Overview
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Patheon Recent Developments
6.12 Beximco Pharma
6.12.1 Beximco Pharma Company Information
6.12.2 Beximco Pharma Large Volume Parenteral (LVP) Business Overview
6.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Beximco Pharma Recent Developments
6.13 Albert David
6.13.1 Albert David Company Information
6.13.2 Albert David Large Volume Parenteral (LVP) Business Overview
6.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Albert David Recent Developments
6.14 PSI Ltd
6.14.1 PSI Ltd Company Information
6.14.2 PSI Ltd Large Volume Parenteral (LVP) Business Overview
6.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.14.5 PSI Ltd Recent Developments
6.15 Ozon Pharmaceuticals
6.15.1 Ozon Pharmaceuticals Company Information
6.15.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Business Overview
6.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.15.5 Ozon Pharmaceuticals Recent Developments
6.16 BAG Healthcare
6.16.1 BAG Healthcare Company Information
6.16.2 BAG Healthcare Large Volume Parenteral (LVP) Business Overview
6.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.16.5 BAG Healthcare Recent Developments
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Company Information
6.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments
5 GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET SCENARIO BY REGION
5.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Large Volume Parenteral (LVP) Sales by Region: 2018-2029
5.2.1 Global Large Volume Parenteral (LVP) Sales by Region: 2018-2023
5.2.2 Global Large Volume Parenteral (LVP) Sales by Region: 2024-2029
5.3 Global Large Volume Parenteral (LVP) Revenue by Region: 2018-2029
5.3.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2018-2023
5.3.2 Global Large Volume Parenteral (LVP) Revenue by Region: 2024-2029
5.4 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.4.1 North America Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.4.3 North America Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.5.1 Europe Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.5.3 Europe Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.6.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.6.3 Asia Pacific Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.7.1 Latin America Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.7.3 Latin America Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.8.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.8.3 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Large Volume Parenteral (LVP) Sales by Type (2018-2029)
6.1.1 Global Large Volume Parenteral (LVP) Sales by Type (2018-2029) & (M Units)
6.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2018-2029)
6.2 Global Large Volume Parenteral (LVP) Revenue by Type (2018-2029)
6.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2018-2029)
6.3 Global Large Volume Parenteral (LVP) Price by Type (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Large Volume Parenteral (LVP) Sales by Application (2018-2029)
7.1.1 Global Large Volume Parenteral (LVP) Sales by Application (2018-2029) & (M Units)
7.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2018-2029)
7.2 Global Large Volume Parenteral (LVP) Revenue by Application (2018-2029)
6.2.1 Global Large Volume Parenteral (LVP) Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2018-2029)
7.3 Global Large Volume Parenteral (LVP) Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Large Volume Parenteral (LVP) Value Chain Analysis
8.1.1 Large Volume Parenteral (LVP) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Large Volume Parenteral (LVP) Production Mode & Process
8.2 Large Volume Parenteral (LVP) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Large Volume Parenteral (LVP) Distributors
8.2.3 Large Volume Parenteral (LVP) Customers
9 GLOBAL LARGE VOLUME PARENTERAL (LVP) ANALYZING MARKET DYNAMICS
9.1 Large Volume Parenteral (LVP) Industry Trends
9.2 Large Volume Parenteral (LVP) Industry Drivers
9.3 Large Volume Parenteral (LVP) Industry Opportunities and Challenges
9.4 Large Volume Parenteral (LVP) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
